Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017

Go back to Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017

Repligen (RGEN) Tops Q4 EPS by 1c

February 22, 2017 7:37 AM EST

Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $25.6 million versus the consensus estimate of $24.05 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

... More